Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eikichi Hosoya.
Epilepsia | 1986
Eiichi Sugaya; Atsushi Ishige; Kyoji Sekiguchi; Susumu Iizuka; Koichi Ito; Akira Sugimoto; Masaki Aburada; Eikichi Hosoya
Summary: The El mouse is an inbred strain developed from ddY mice and is very susceptible to seizure. In El mice, convulsions could be induced by 18 mg/kg of pentylenetetrazol, which is an inert dose in ddY mice. The features of the convulsions were the same as those induced by the tossing‐up procedure, a common method to evoke convulsions in El mice. Phenytoin, phenobarbital, valproate sodium, and ethosuximide clearly inhibited pentylenetetrazol‐induced convulsions in El mice. These findings suggest that induction of convulsions by pentylenetetrazol in the El mouse is a simple method as compared with induction of convulsions by the tossing‐up procedure, and convulsions evoked by this method are a precise experimental model for the study of hereditary epilepsy and for the evaluation of anticonvulsant drugs.
Brain Research | 1987
Eiichi Sugaya; Hiroaki Asou; Kouichi Itoh; Atsushi Ishige; Kyoji Sekiguchi; Susumu Iizuka; Akira Sugimoto; Masaki Aburada; Eikichi Hosoya; Tamaki Takagi; Kagemasa Kajiwara; Junichi Komatsubara; Shusuke Hirano
To elucidate the differences between neurons of epileptogenic animals and those of normal animals, cellular characteristics of neurons of mutant strain El mice which are highly susceptible to seizures were investigated using immunocytochemical techniques. In neurons of 3-day primary cultures, the control ddY mouse neurons showed dividing stages in about 0.2% of neurofilament (NF)-positive neurons, whereas no dividing neurons were observed among the NF-positive El mouse neurons. In 7-day cultures, localization of GD3 ganglioside in the proliferating control ddY mouse neurons was observed, but there was no GD3 ganglioside in the mutant El mouse neuron. The content of GD3 ganglioside detected by high-performance thin-layer chromatography of El mouse cultured cells was ca. 1/4 of that of ddy mice. These findings suggest that neurons of the El mouse are differentiated earlier than those of the control ddY mouse.
Epilepsy Research | 1988
Eiichi Sugaya; Atsushi Ishige; Kyoji Sekiguchi; Susumu Iizuka; Akira Sugimoto; Mitsutoshi Yuzurihara; Eikichi Hosoya
TJ-960 is a spray-dried mixture of 9 herbal drugs. The convulsions of E1 mice induced by pentylenetetrazol (18 mg/kg) were completely inhibited by p.o. administration of TJ-960 at a daily dose of 1.0 g/kg both in 8-week-old and 4-week-old E1 mice. These findings suggest that TJ-960 has an inhibitory effect on the convulsions of this hereditary animal model of epilepsy.
Epilepsy Research | 1988
Eiichi Sugaya; Atsushi Ishige; Kyoji Sekiguchi; Susumu Iizuka; Kouichi Ito; Akira Sugimoto; Masaki Aburada; Eikichi Hosoya
Effects of the Japanese kampo medicine Shosaiko-to-go-keishika-shyakuyaku-to (TJ-960), which is a mixture of 9 herbal drugs and is practically equivalent to Saiko-keishi-to (SK), on the pentylenetetrazol (PTZ)-induced EEG power spectrum changes were examined. The EEG power spectrum change with 2 PTZ administrations at an 80 min interval was clearly inhibited by oral administration of 1.0 mg/kg of TJ-960. By separate single administrations of the main component herbal drugs, Bupleuri radix, Cinnamomi cortex, Paeoniae radix and Zingiberis rhizoma, only Paeoniae radix showed statistically significant inhibition of PTZ-induced EEG power spectrum changes at a proportional dose of 1.0 mg/kg of TJ-960. The other main component herbal drugs showed no statistically significant inhibitory effect although they had a tendency to inhibit. These findings suggest that the Japanese Kampo medicine, TJ-960 (SK), has an inhibitory effect on PTZ-induced power spectrum changes and one of the component herbal drugs, Paeoniae radix, is the important component drug.
Brain Research | 1988
Eiichi Sugaya; Atsuchi Ishige; Kyoji Sediguchi; Mitsutoshi Yuzurihara; Susumu Iizuka; Akira Sugimoto; Eikichi Hosoya
The relationship between the focus of cobalt seizures in the cerebral cortex and neuron loss in the hippocampus, as well as the CD50 of pentylenetetrazol was examined in rats. Spike activity in EEG frequently appeared 4 days after cobalt application and reached a peak 8-16 days after cobalt application, which was sometimes accompanied by jerks in the limbs. Changes in the CD50 value showed a two-step pattern, i.e., the first decrease in CD50 appeared one day after application of cobalt and continued at the same value until the fourth day. Then a second gradual decrease of CD50 was observed from the fourth day to eighth day and continued at the same value until 20 days after cobalt application. Neuron loss in the CA1 area of the hippocampus was observed as early as two days after cobalt application and the degree of neuron loss progressively increased until the 20th day. These findings suggest that neuron loss in the hippocampus following cobalt-induced seizures is not a result of generalized convulsions.
Epilepsy Research | 1987
Eiichi Sugaya; Atsushi Ishige; Kyoji Sekiguchi; Susumu Iizuka; Kenji Sakamoto; Yutaka Matsuzaki; Masaki Aburada; Eikichi Hosoya
The effect of anticonvulsants on pentylenetetrazol (PTZ)-induced EEG power spectrum changes was examined. When the minimum dose of PTZ (15 mg/kg) was administered intravenously twice, with an interval of 80 min, a clear EEG power spectrum change was observed after the second PTZ administration, irrespective of whether or not the first PTZ administration evoked marked EEG changes. We defined the values F/N, S/N and S/F. The value F/N, obtained by dividing the power spectrum area after the first PTZ administration by the normal power spectrum area, was 1.06 +/- 0.05 (mean +/- S.E.). The value S/N, obtained by dividing the power spectrum area after the second PTZ administration by the normal power spectrum area, was 2.00 +/- 0.21. The value S/F, obtained by dividing S/N by F/N, was 1.86 +/- 0.16. The S/F value was almost constant regardless of whether or not the first PTZ administration could evoke marked EEG changes. The effect of anticonvulsants was examined by S/F value changes, and 100 mg/kg of PHT completely inhibited the double PTZ effect. Phenobarbital, ethosuximide and sodium valproate also inhibited the double PTZ effect. Using the S/F value of the EEG power spectrum with minimum dose double PTZ administration, quantitative evaluation is possible for anticonvulsant drugs.
Journal of pharmacobio-dynamics | 1984
Mamoru Suekawa; Atsushi Ishige; Kazunori Yuasa; Kazuhiko Sudo; Masaki Aburada; Eikichi Hosoya
Journal of pharmacobio-dynamics | 1983
Masaki Aburada; Shigefumi Takeda; Eiko Ito; Moe Nakamura; Eikichi Hosoya
Journal of pharmacobio-dynamics | 1986
Mamoru Suekawa; Masaki Aburada; Eikichi Hosoya
Folia Pharmacologica Japonica | 1986
Mamoru Suekawa; Kazunori Yuasa; Masanao Isono; Hideko Sone; Yukinobu Ikeya; Iwao Sakakibara; Masaki Aburada; Eikichi Hosoya